# CYP3A4 Inhibitors

**Strong**: ≥5-fold increase in the plasma AUC values (>80% decrease in clearance)

**Moderate**: ≥2-fold increase in the plasma AUC values (50–80% decrease in clearance)

**Weak**: ≥1.25-fold and <2-fold increase in the plasma AUC values (20–50% decrease in clearance)

## Strong inhibitors

- protease inhibitors
    - boceprevir
    - ritonavir
    - indinavir
    - nelfinavir
    - saquinavir
- macrolide antibiotics
    - clarithromycin
    - erythromycin
    - telithromycin
- ceritinib
- mibefradil
- nefazodone
- ribociclib
- tucatinib
- chloramphenicol
- azole antifungals
    - ketoconazole
    - itraconazole
    - posaconazole
    - voriconazole
- cobicistat
- green tea extract
- grape seed extract
- dillapiole
- apigenin

## Moderate inhibitors

- amiodarone
- aprepitant
- ciprofloxacin
- conivaptan
- crizotinib
- rutin
- tofisopam
- calcium channel blockers
    - verapamil
    - diltiazem
- azole antifungals
    - fluconazole
    - miconazole
- bergamottin
- cyclosporine
- donedarone
- fluvoxamine
- imatinib
- valerian

## Weak inhibitors

- berberine
- buprenorphine
- cafestol (in unfiltered coffee)
- cilostazol
- cimetidine
- fosaprepitant
- lomitapide
- orphenadrine
- omeprazole
- quercetin
- ranitidine
- ranolazine
- tacrolimus
- ticagrelor
- valproic acid
- amlodipine
- azithromycin

## Inhibitors of unspecified potency

- cannabidiol
- dithiocarbamate
- mifepristone
- norfloxacin
- antiretroviral drugs
    - delavirdine
- gestodene
- star fruit
- milk thistle
- niacin
- ginkgo biloba
- sesamin
- piperine
- isoniazid
- serenoa